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Abstract: Many rural communities have poor access to health services due to a combination of
distance from specialist services and a relative shortage of general practitioners. Our aims were
to compare the characteristics of urban and rural women with breast cancer in New Zealand,
to assess breast cancer-specific and all-cause survival using the Kaplan–Meier method and Cox
proportional hazards model, and to assess whether the impact of rurality is different for Māori and
New Zealand (NZ) European women. We found that rural women tended to be older and were
more likely to be Māori. Overall there were no differences between urban and rural women with
regards their survival. Rural Māori tended to be older, more likely to be diagnosed with metastatic
disease and less likely to be screen detected than urban Māori. Rural Māori women had inferior
breast cancer-specific survival and all-cause survival at 10 years at 72.1% and 55.8% compared to
77.9% and 64.9% for urban Māori. The study shows that rather than being concerned that more needs
to be done for rural women in general it is rural Māori women where we need to make extra efforts
to ensure early stage at diagnosis and optimum treatment.
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1. Introduction
Many rural communities have poor access to health services due to a combination of distance
from specialist services and a relative shortage of general practitioners. These disadvantages can
lead to differences in health outcomes. Breast cancer is the most commonly diagnosed cancer in
New Zealand (NZ) women with 3000 new cases each year. It is also an important cause of death with
617 deaths per year [1]. Urban rural differences in breast cancer are well known. A comprehensive
systematic review of the international literature suggested rural women were 19% more likely to be
diagnosed with advanced stage at diagnosis [2]. Differences in mortality have also been shown between
urban and rural women with breast cancer in Scotland [3], South Australia [4] and Germany [5]. It is
difficult to generalise the findings from international studies as the definition of rurality can vary.
For instance rural and remote communities in Australia and Canada will involve much greater
distances from an urban medical centre than would be the case in Europe where population densities
are greater.
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In New Zealand, differences have been shown in the presentation and outcomes of breast cancer
for Māori and Pacific women compared with NZ Europeans [6,7]. A prior study using NZ cancer
registry data did not show differences in breast cancer mortality or stage of diagnosis for urban versus
rural women after adjustment for age, ethnicity and socioeconomic status [8]. However the NZ cancer
registry data has missing data and limited information on other characteristics that may influence
outcomes, and the missing data may be differential by urban/rural status. For example, it may be that
those living in more rural areas are more likely to have data missing. There is also variation in the
definition of what is considered a rural population. This study is based on substantially more detailed
clinical data available (including accurate staging, screening history and presence of biological markers)
from two clinical breast cancer registers in the Waikato and Auckland regions [9]. Waikato District
Health Board has a large rural community with 60% of patients living outside the main centre of
Hamilton, while Auckland on the other hand is mainly an urban community. Our aims were (1) to
compare the differences and characteristics of rural women particularly stage of diagnosis and tumour
size as these are important measures of differences in diagnosis; (2) to assess breast cancer-specific and
all-cause survival for urban and rural women with breast cancer; and (3) to assess whether the impact
of rurality is different for Māori and NZ European women in New Zealand.
2. Methods
The population for this study included all women diagnosed with invasive breast cancer in the
Waikato and Auckland regions from June 2000 to May 2013. The two registers have been collecting data
prospectively on newly diagnosed women with breast cancer and have accurate data on demographic
characteristics including place of domicile as well as clinical data on the breast cancer at diagnosis and
subsequent treatment. Ethical approval for this study was obtained from the New Zealand Northern
“A” Health and Disability Ethics Committee (Ref. No. 12/NTA/42).
The definition of urban and rural varies considerably across different studies and countries.
Within NZ a number of different definitions have been considered [10,11]. For this study we have
taken the seven different classifications of the urban rural profile classification basis of NZ statistics
which is based on both domicile and work place. The seven categories are Major Urban; Satellite Urban;
Independent Urban; Rural with high urban influence; Rural with moderate urban influence; Rural with
low urban influence and Highly Rural/Remote. We have categorised rural areas with high urban
influence to be urban as these communities generally are the high socioeconomic population living
close to urban centres where these families work, shop and receive health care. On the other hand the
NZ independent urban centres are those independent towns where general practitioners are classified
as being rural and receive a rural bonus. Consequently we have redefined urban as either a major or
satellite urban community or communities of high urban influence. Rural we have considered to be
independent urban communities or those designated rural with moderate or low or no urban influence.
Other variables included in the study were: age (<40, 40–49, 50–59, 60–69, 70–79, 80+ years),
ethnicity (NZ European, Māori, Pacific, Asian, others), cancer stage (I, II, III, IV), grade (1, 2, 3),
tumour size (0–10, 10–20, 20–30, 30–50, 50+ mm), mode of detection (screen detected, not screen
detected), and hormone status (Estrogen receptor (ER) and progesterone receptor (PR) negative,
ER and/or PR positive). We first compared the characteristics between urban and rural women,
and then compared urban and rural Māori and NZ European women. Key demographic and disease
characteristics were described for the total cohort, for urban and rural populations and stratified
by ethnicity.
Mortality information including date of death and cause of death were from both the combined
registers and the Mortality Collection in New Zealand. For all-cause survival analyses, patients without
mortality information were considered to be censored on the last updated date for Mortality Collection
which was 31 December 2014. For cancer-specific analyses, deaths from other causes were censored on
the date of death. Cancer-specific and all-cause survival were assessed for rural and urban women at
5 and 10 years using Kaplan–Meier method. Models were fitted using Cox proportional hazards models
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with cancer-specific and all-cause deaths as outcomes of interests, to compare outcomes for rural
compared with urban women for the whole cohort and stratified by ethnicity. The proportional hazards
assumption was tested for both breast cancer-specific and total mortality by creating a time-dependent
covariate as an interaction term between urban-rural residence and survival time. The survival
difference between subgroups was considered significant if the p-value was less than 0.05. All data
analyses were performed in SPSS (IBM Corporation, New York, NY, USA).
3. Results
There were 12,372 women on the two registers with a diagnosis of invasive breast cancer.
2364 were classified as rural, living in an independent rural centre or a rural community, and 9885 were
classified as urban (in 123 women domicile was not classified). When comparing the characteristics of
urban and rural women with breast cancer, rural women tended to be older and were more likely to be
Māori (Table 1). Stage of disease at diagnosis was similar and tumour size was also similar with 51.7%
of rural women having a tumour size less than 20 mm and 50.3% of urban women (p = 0.238).
Table 1. Characteristics of urban and rural women.
Characteristics Rural Urban Total p-Value (Chi-Square Test)
Age Groups <0.001
<40 126 5.3% 669 6.8% 795 6.5%
40–49 401 17.0% 2263 22.9% 2664 21.7%
50–59 626 26.5% 2689 27.2% 3315 27.1%
60–69 600 25.4% 2233 22.6% 2833 23.1%
70–79 364 15.4% 1178 11.9% 1542 12.6%
80+ 247 10.4% 853 8.6% 1100 9.0%
Cancer Stage 0.066
I 997 42.2% 4291 43.4% 5288 43.2%
II 890 37.6% 3643 36.9% 4533 37.0%
III 345 14.6% 1514 15.3% 1859 15.2%
IV 132 5.6% 437 4.4% 569 4.6%
Grade <0.001
1 557 25.3% 2270 24.1% 2827 24.4%
2 1113 50.5% 4281 45.5% 5394 46.5%
3 535 24.3% 2850 30.3% 3385 29.2%
Unknown 159 484 643
Tumour Size (mm) 0.238
0–20 1123 51.7% 4726 50.3% 5849 50.5%
20+ 1050 48.3% 4674 49.7% 5724 49.5%
Unknown 191 485 676
Mode of Detection 0.909
Not screen detected 1458 61.7% 6084 61.5% 7542 61.6%
Screen detected 906 38.3% 3801 38.5% 4707 38.4%
ERPR 0.034
ER and PR negative 395 17.1% 1840 19.0% 2235 18.7%
ER and/or PR positive 1910 82.9% 7819 81.0% 9729 81.3%
Unknown 59 226 285
Ethnicity <0.001
NZ European 1932 82.2% 6943 71.2% 8875 73.3%
Māori 311 13.2% 844 8.7% 1155 9.5%
Pacific 38 1.6% 759 7.8% 797 6.6%
Asian 47 2.0% 920 9.4% 967 8.0%
Others 22 0.9% 285 2.9% 307 2.5%
Unknown 14 134 148
Total 2364 100% 9885 100% 12,249 100%
ER: Estrogen receptor; RP: Progesterone receptor; NZ: New Zealand.
When we stratified by ethnicity, we find that rural Māori tended to be older, more likely to be
diagnosed with metastatic breast cancer (p < 0.01) and less likely to be screen detected than urban
Māori (Table 2). Rural NZ European were older and less likely to be diagnosed with Grade 3 cancer,
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but otherwise they had similar characteristics to urban NZ European including similar screen detected
rates and similar stage at diagnosis.
Table 2. Urban and rural women Māori and NZ European.
Characteristics
Māori NZ European
Rural Urban Total Rural Urban Total
Age Groups
p-Value (Chi-Square Test) 0.043 <0.001
<40 23 7.4% 74 8.8% 97 8.4% 95 4.9% 407 5.9% 502 5.7%
40–49 66 21.2% 238 28.2% 304 26.3% 303 15.7% 1391 20.0% 1694 19.1%
50–59 100 32.2% 264 31.3% 364 31.5% 488 25.3% 1796 25.9% 2284 25.7%
60–69 82 26.4% 183 21.7% 265 22.9% 491 25.4% 1650 23.8% 2141 24.1%
70–79 29 9.3% 72 8.5% 101 8.7% 324 16.8% 926 13.3% 1250 14.1%
80+ 11 3.5% 13 1.5% 24 2.1% 231 12.0% 773 11.1% 1004 11.3%
Cancer Stage
p-Value (Chi-Square Test) 0.076 0.178
I 112 36.0% 315 37.3% 427 37.0% 837 43.3% 3136 45.2% 3973 44.8%
II 112 36.0% 313 37.1% 425 36.8% 726 37.6% 2546 36.7% 3272 36.9%
III 53 17.0% 162 19.2% 215 18.6% 279 14.4% 1003 14.4% 1282 14.4%
IV 34 10.9% 54 6.4% 88 7.6% 90 4.7% 258 3.7% 348 3.9%
Grade
p-Value (Chi-Square Test) 0.065 <0.001
1 56 19.7% 181 22.5% 237 21.7% 469 26.0% 1673 25.4% 2142 25.5%
2 158 55.6% 384 47.6% 542 49.7% 905 50.1% 3009 45.6% 3914 46.6%
3 70 24.6% 241 29.9% 311 28.5% 432 23.9% 1911 29.0% 2343 27.9%
Unknown 27 38 65 126 350 476
Tumour Size (mm)
p-Value (Chi-Square Test) 0.033 0.949
0–20 130 48.0% 322 40.6% 452 42.4% 945 52.9% 3497 52.9% 4442 52.9%
20+ 141 52.0% 472 59.4% 613 57.6% 843 47.1% 3109 47.1% 3952 47.1%
Unknown 40 50 90 144 337 481
Mode of detection
p-Value (Chi-Square Test) 0.323 0.960
Not screen detected 208 66.9% 538 63.7% 746 64.6% 1170 60.6% 4209 60.6% 5379 60.6%
Screen detected 103 33.1% 306 36.3% 409 35.4% 762 39.4% 2734 39.4% 3496 39.4%
ERPR
p-Value (Chi-Square Test) 0.389 0.124
ER and PR negative 55 18.0% 131 15.8% 186 16.4% 324 17.2% 1275 18.8% 1599 18.4%
ER and/or PR positive 251 82.0% 696 84.2% 947 83.6% 1558 82.8% 5518 81.2% 7076 81.6%
Unknown 5 17 22 50 150 200
Total 311 100% 844 100% 1155 100% 1932 100% 6943 100% 8875 100%
ER: Estrogen receptor; RP: Progesterone receptor; NZ: New Zealand.
When comparing 5-year and 10-year survival for urban versus rural women, we found that breast
cancer survival is very similar for urban and rural women overall, but that for Māori women survival
appears to be worse for rural compared with urban women (Table 3). Rural Māori women had inferior
breast cancer-specific survival at 10 years at 72.1% compared to 77.9% for urban Māori (p = 0.072).
The 5-year and 10-year all-cause survival was 71.6% and 55.8% for rural Māori women compared to
77.9% and 64.9% for urban Māori women (p = 0.017).
The hazard ratios for mortality using the Cox proportional hazards model (Table 4) showed
that rural NZ European women have similar breast cancer-specific mortality and all-cause mortality
compared to urban NZ European women after adjustment for age, cancer stage, tumour size, grade,
hormonal status (ERPR), year of diagnosis, mode of detection and comorbidity. However, survival was
poorer for rural Māori women compared with urban Māori women for both cancer-specific and
all-cause survival. The unadjusted hazard ratio for breast cancer-specific mortality and the
all-cause mortality for rural Māori compared with urban Māori was 1.31 (95% CI 0.97–1.76) and
1.33 (95% CI 1.05–1.68), respectively. The hazard ratio increased to 1.47 (95% CI 1.00–2.16) and
1.43 (95% CI 1.08–1.91), respectively, after adjustment for other factors. The proportionality assumption
was tested for each of the 6 models shown in Table 4, with no significant departure from proportionality
shown in all models except that of all rural versus all urban women for total mortality, where there
Int. J. Environ. Res. Public Health 2016, 13, 1000 5 of 7
was significant evidence of interaction between urban-rural residence and survival time on the hazard
ratio (p = 0.029).
Table 3. 5-year and 10-year breast cancer-specific survival and all-cause survival by Kaplan–Meier method.
Groups 5-Year (95% CI) 10-Year (95% CI) Log Rank Test(p-Value)
Breast cancer-specific survival
Rural women 86.6% (85.1%–88.1%) 81.5% (79.6%–83.4%) 0.211
Urban women 88.0% (87.3%–88.7%) 82.5% (81.5%–83.4%)
Rural Māori women 78.3% (73.2%–83.5%) 72.1% (65.8%–78.5%) 0.072
Urban Māori women 84.1% (81.4%–86.8%) 77.9% (74.2%–81.5%)
Rural European women 87.9% (86.3%–89.4%) 82.7% (80.7%–84.8%) 0.605
Urban European women 88.6% (87.8%–89.4%) 83.0% (81.9%–84.1%)
All-cause survival
Rural women 80.6% (78.9%–82.3%) 67.8% (65.4%–70.2%) 0.007
Urban women 82.7% (81.9%–83.4%) 71.2% (70.1%–72.4%)
Rural Māori women 71.6% (66.2%–77.0%) 55.8% (48.2%–63.3%) 0.017
Urban Māori women 77.9% (74.9%–80.9%) 64.9% (60.6%–69.2%)
Rural European women 81.9% (80.0%–83.7%) 69.0% (66.4%–71.6%) 0.394
Urban European women 82.0% (81.1%–83.0%) 70.3% (69.0%–71.7%)
Table 4. Hazard ratio for mortality estimated by Cox proportional hazards model.




Rural women compared with urban women 1.08 (0.96–1.22) 1.01 (0.87–1.17)
Rural Māori women compared with urban Māori women 1.31 (0.97–1.76) 1.47 (1.00–2.16)
Rural European women compared with urban European women 1.04 (0.90–1.19) 0.94 (0.79–1.10)
All-cause mortality
Rural women compared with urban women 1.13 (1.03–1.24) * 1.04 (0.94–1.16)
Rural Māori women compared with urban Māori women 1.33 (1.05–1.68) * 1.43 (1.08–1.91) *
Rural European women compared with urban European women 1.05 (0.94–1.16) 0.90 (0.80–1.02)
1 Adjusted for age, (ethnicity), cancer stage, tumour size, grade, hormonal status (ERPR), year of diagnosis,
mode of detection and comorbidity. * p-Value < 0.05.
4. Discussion
The key findings from this study is that there is no evidence that rural women in New Zealand
are more likely to present with advanced stage of disease or have poorer outcomes. In our two regions
it appears that rural women with breast cancer are older than urban women and that there are
proportionately more rural Māori than urban Māori. The cancer-specific mortality rates for rural
women were similar suggesting that access to breast cancer treatment is at least as good for rural
women as urban.
However for Māori women with breast cancer outcomes are worse than for urban Māori.
Rural Māori women do have lower rates of screen detected cancer and higher rates of metastatic
disease. Overall there is a suggestion that both their breast cancer-specific mortality rate and all-cause
mortality rate are not improved compared with urban Māori and may even be over 40% worse.
One possible explanation for this is that deprivation may be more of an issue for Māori living in rural
areas compared with non-Māori women which may have an additionally deleterious effect on survival.
Similar observations have been reported from the USA. In one study socio-economic deprivation for
native American Indians appeared to be more important than rurality [12] while in another study
rural black American women were less likely to be screened and had more advanced disease at
diagnosis [13]. Within New Zealand we know that there are health system barriers for Māori women
with breast cancer. These include access to primary care and that when accessing specialist care lack of
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transport was a barrier—a key factor for rural women [14]. Access to primary care is important in that
it has been shown that the more general practitioners per population, the earlier stage of diagnosis [15].
These findings are similar to those of our previous study using cancer registry data which showed
no difference in stage or survival in rural women after adjustment for demographic factors. The screen
detection rates in our rural women are re-assuring and suggest that our breast screening programs in
Auckland and the Waikato are reaching rural women. The main concern is the overall lower rate in
Māori women. These disparities are being addressed by Breast-screen Aoteoaroea. We have shown
that rural Māori women can achieve high rates of breast screening if a concerted general practice based
approach is taken to encouraging mammographic screening [16]. One of the factors that has been
noted in Australia linked to poorer outcomes has been that rural women may be treated in a smaller
centre by a low case load surgeon [17]. This is not a factor in our study as all women were treated in
a high case load centre either in Auckland or Waikato. This may be one explanation for the lack of
difference in overall outcomes.
The strengths of this study are that it is based on data from complete and high quality registers
which have been collected prospectively. The weakness is that the study is dominated by the high
number of urban women and relatively small numbers of rural Māori (311) which mean the results
relating to Māori are less stable than the remainder of the results.
5. Conclusions
The study shows that, rather than being concerned that more needs to be done for rural women
in general, it is rural Māori women where we need to make extra efforts to improve the later stage at
diagnosis and ensure optimum treatment if we are to achieve equity in outcomes.
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